STAT

STAT+: Pharmalittle: Lilly signs $375 million deal with U.S. for Covid-19 drug; Sanofi and Glaxo will supply vaccine to COVAX

Sanofi and GlaxoSmithKline plan to make 200 million doses of their Covid-19 vaccine candidate available to the COVAX vaccine allocation plan.
Source: Alex Hogan/STAT

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far. This is cause for

Sie lesen eine Vorschau. Registrieren Sie sich, um mehr zu lesen.

Mehr von STAT

STAT1 min gelesen
STAT+: Pharmalittle: Hospitals Grapple With Extra Dose Of Pfizer Vaccine; FDA Panel Meets To Review Moderna Vaccine
With the Covid-19 vaccine in short supply, hospital pharmacists found themselves throwing away one in every six doses of the first vaccines distributed this week in the U.S.
STAT1 min gelesenMedical
STAT+: Pharmalittle: U.S. Considers Giving Half-doses Of Moderna Vaccine; Americans May Not Get AstraZeneca Shot Until April
The U.S. government is considering giving some people half the dose of the Moderna Covid-19 vaccine in order to speed vaccinations.
STAT1 min gelesenMedical
STAT+: Pharmalittle: FDA Panel Endorses Moderna Covid-19 Vaccine; Sacklers Dodge Blame For Opioid Crisis At Hearing
An FDA advisory panel recommended the agency issue an emergency use authorization for the Moderna Covid-19 vaccine, all but guaranteeing the agency will do so.